Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Alexion Pharmaceuticals Inc (ALXN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2021 Q2 | 11,420 | 0.02 | Reduce 62.32% | 0.02 | $183.71 | $2,098,000 | SEC |
| 2021 Q1 | 30,309 | 0.04 | Buy | 0.04 | $152.92 | $4,635,000 | SEC |
| 2020 Q4 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2020 Q3 | 10,959 | 0.02 | Reduce 18.42% | <0.01 | $114.43 | $1,254,000 | SEC |
| 2020 Q2 | 13,434 | 0.03 | Add 533.98% | 0.03 | $112.25 | $1,508,000 | SEC |
| 2020 Q1 | 2,119 | <0.01 | Buy | <0.01 | $89.66 | $190,000 | SEC |
| 2015 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2015 Q2 | 1,600 | <0.01 | Add 18.52% | <0.01 | $180.63 | $289,000 | SEC |
| 2015 Q1 | 1,350 | <0.01 | Buy | <0.01 | $173.33 | $234,000 | SEC |
| 2005 Q4 | 0 | 0.00 | Sell 100.00% | 0.54 | SEC | ||
| 2005 Q3 | 1,535,759 | 0.54 | Buy | 0.54 | $27.65 | $42,464,000 | SEC |
| 2004 Q4 | 0 | 0.00 | Sell 100.00% | 0.13 | SEC | ||
| 2004 Q3 | 435,000 | 0.13 | Buy | 0.13 | $18.00 | $7,830,000 | SEC |